Nov 21, 2025 14:00
CRMD - CorMedix Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 9.56 0.14 (1.52%) | 0.01 (0.1%) | 0.02 (0.17%) | 0.03 (0.26%) | -0.06 (-0.63%) | 0.18 (1.84%) | 0.12 (1.25%) | -0.1 (-1.04%) |
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- 0.29
- Diluted EPS:
- 0.28
- Basic P/E:
- 33.4655
- Diluted P/E:
- 34.6607
- RSI(14) 1m:
- 84.62
- VWAP:
- 9.7
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Nov 12, 2025 16:00
Sep 29, 2025 12:30
Sep 02, 2025 11:30
Dec 10, 2024 07:45
Sep 09, 2024 20:06
Sep 09, 2024 14:52
Jun 06, 2024 12:30
May 09, 2024 15:00
May 09, 2024 11:30